Position in NVS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$440,226
+$9,471 QoQ
Shares Held
2,809
-0.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#949
of 1,603 holders
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Integrated Advisors Network LLC holds $55,348,452 across 12 Drug Manufacturers - General names. NVS ranks #8 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
14,637 | $17,556,058 | |
| 2 | ABBV |
AbbVie Inc.
|
46,747 | $11,763,415 | |
| 3 | JNJ |
Johnson & Johnson
|
32,020 | $8,132,119 | |
| 4 | MRK |
Merck & Co., Inc.
|
54,726 | $7,032,291 | |
| 5 | AMGN |
Amgen Inc
|
18,675 | $6,762,591 | |
| 6 | PFE |
Pfizer Inc
|
56,176 | $1,352,718 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
17,597 | $1,013,939 | |
| 8 | NVS |
Novartis AG
This page
|
2,809 | $440,226 |
All Filings in NVS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $440,226 | 2,809 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $430,755 | 2,820 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $280,979 | 2,038 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $342,657 | 2,672 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $201,239 | 1,663 | Shares | Sole | 2025-08-12 | |
| 2024-09-30 | $270,181 | 2,349 | Shares | Sole | 2024-10-25 | |
| 2020-06-30 | $332,502 | 3,807 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,269,766 | 27,529 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||